555
Participants
Start Date
August 31, 2010
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
Insulin Glargine
"Pharmaceutical form: solution for injection~Route of administration: subcutaneous~Dose regimen: initial: once a day in the evening at bedtime. Titration will occur each time the middle FPG (Fasting Plasma Glucose) value is above target"
Administrative office, Shanghai
Administrative office, Mumbai
Administrative office, Tokyo
Administrative office, Karachi
Administrative office, Makati City
Administrative office, Moscow
Lead Sponsor
Sanofi
INDUSTRY